3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
17
Multiple Myeloma
14
Precursor Cell Lymphoblastic Leukemia-Lymphoma
13
Myelodysplastic Syndromes
13
Neuroblastoma
4
Lymphoma, Non-Hodgkin
4
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
4
Hodgkin Disease
4
Hematologic Neoplasms
4
Neoplasm, Residual
3
Myeloproliferative Disorders
3
Lymphoma
3
Anemia, Refractory, with Excess of Blasts
3
Leukemia, Myelomonocytic, Juvenile
2
Leukemia, Biphenotypic, Acute
2
Graft vs Host Disease
2
Ganglioneuroblastoma
2
Burkitt Lymphoma
2
beta-Thalassemia
1
Waldenstrom Macroglobulinemia
1
Venentoclax
1
Smoldering Multiple Myeloma
1
Sarcoma, Ewing
1
Rhabdomyosarcoma
1
Recurrence
1
Rectal Neoplasms
1
Preleukemia
1
Precancerous Conditions
1
Plasmablastic Lymphoma
1
Osteosarcoma
1
Interventions
Doxorubicin
14
pembrolizumab
11
Specimen Handling
11
Magnetic Resonance Spectroscopy
10
Biopsy
9
Cyclophosphamide
8
X-Rays
7
Radiotherapy
7
Nivolumab
7
Ifosfamide
7
Phantoms, Imaging
6
Gemcitabine
6
liposomal doxorubicin
5
Temozolomide
5
Radiation
5
tazemetostat
4
palbociclib
4
Trabectedin
4
Nuclear Medicine Department, Hospital
4
Irinotecan
4
Ipilimumab
4
pazopanib
3
larotrectinib
3
fludarabine
3
cabozantinib
3
atezolizumab
3
Surveys and Questionnaires
3
Radiation Dose Hypofractionation
3
Proton Therapy
3
Carboplatin
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Sarcoma
×
Melphalan
×
90 days
×
Clear all
No trials found.